(Rac)-EC5026_product_DataBase

CAS: 1809885-55-9 F: C18H23F4N3O3 W: 405.39

(Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) extracted from patent

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity

(Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) extracted from patent WO2019156991A1, page 39, has a Ki of 0.06 nM. (Rac)-EC5026 can be used for the research of Parkinson's disease and dementia with Lewy Bodies (DLB)[1].

Target

Ki: 0.06 nM (sEH)]

Invitro

(Rac)-EC5026 inhibits soluble epoxide hydrolase (sEH), with a Ki of 0.06 nM[1].

Name

(Rac)-EC5026

CAS

1809885-55-9

Formula

C18H23F4N3O3

Molar Mass

405.39

Appearance

Solid

Transport

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Reference

[1]. Hammock BD, et, al. Methods of inhibiting formation of alpha synuclein aggregates. WO2019156991A1.

PeptideDB

(Rac)-EC5026

CAS: 1809885-55-9 F: C18H23F4N3O3 W: 405.39